Effect of adrenalectomy and corticosterone replacement on prepulse inhibition and locomotor activity in mice

British Journal of Pharmacology

Volumn 142, Issue 3, 2004, Pages 543-550

  Van Den Buuse, Maarten ^a,b   Morris, Margaret ^b   Chavez, Carolina ^a   Martin, Sally ^a   Wang, JianHong ^a,c  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Corticosterone; Dopamine; Locomotor hyperactivity; Mice; Prepulse inhibition

Indexed keywords

AMPHETAMINE; CHOLESTEROL; CORTICOSTERONE; HALOPERIDOL; ISOFLURANE;

ADRENALECTOMY; ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HORMONE SUBSTITUTION; HYPERACTIVITY; IMPLANTATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; STARTLE REFLEX; STATISTICAL SIGNIFICANCE;

ADRENALECTOMY; AMPHETAMINE; ANIMALS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURAL INHIBITION; SCHIZOPHRENIA; STARTLE REACTION;

EID: 3042742584     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705511     Document Type: Article

References (51)

1. BARROT, M., MARINELLI, M., ABROUS, D.N., ROUGE-PONT, F., LE MOAL, M. & PIAZZA, P.V. (2000). The dopaminergic hyperresponsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur. J. Neurosci., 12, 973-979.
2. BENES, F.M. (1997). The role of stress and dopamine - GABA interactions in the vulnerability for schizophrenia. J. Psychiatric Res., 31, 257-275.
3. BIRON, D., DAUPHIN, C. & DI PAOLO, T. (1992). Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors. Neuroendocrinology, 55, 468-476.
4. BIRT, D.F., DUYSEN, E., WANG, W. & YAKTINE, A. (2001). Corticosterone supplementation reduced selective protein kinase C isoform expression in the epidermis of adrenalectomised mice. Cancer Epidemiol. Biomarkers Prev., 10, 679-685.
5. BRAFF, D.L. & GEYER, M.A. (1990). Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry, 47, 181-188.
6. BRAFF, D.L., GRILLON, C. & GEYER, M.A. (1992). Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry, 49, 206-215.
7. BULLOCK, A.E., SLOBE, B.S., VÁZQUEZ, V. & COLLINS, A.C. (1997). Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response. Behav. Neurosci., 111, 1353-1360.
8. CADOR, M., DULLUC, J. & MORMÈDE, P. (1993). Modulation of the locomotor response to amphetamine by corticosterone. Neuroscience, 56, 981-988.
9. CLAUSTRE, Y., RIVY, J.P., DENNIS, T. & SCATTON, B. (1986). Pharmacological studies on stress-induced increase in frontal cortex dopamine metabolism in the rat. J. Pharmacol. Exp. Ther., 238, 693-700.
10. CONTI, L.H., MURRY, J.D., RUIZ, M.A. & PRINTZ, M.P. (2002). Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology, 161, 296-303.
11. CREESE, I. & IVERSEN, S.D. (1975). The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res., 83, 419-436.
12. DE KLOET, E.R., VREUGDENHIL, E., OITZL, M.S. & JOELS, M. (1998). Brain corticosteroid receptor balance in health and disease. Endocrine Rev., 19, 269-301.
13. DEROCHE, V., MARINELLI, M., MACCARI, S., Le MOAL, M., SIMON, H. & PIAZZA, P.V. (1995). Stress-induced sensitization and glucocorticoids. 1. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion.. J. Neurosci., 15, 7181-7188.
14. DIRKS, A., GROENINK, L., WESTPHAL, K.G., OLIVIER, J.D., VERDOUW, P.M., VAN DER GUGTEN, J., GEYER, M.A. & OLIVIER, B. (2003). Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs. Neuropsychopharmacology, 28, 1790-1798.
15. DREVETS, W.C., GAUTIER, C., PRICE, J.C., KUPFER, D.J., KINAHAN, P.E., GRACE, A.A., PRICE, J.L. & MATHIS, C.A. (2001). Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry, 49, 81-96.
16. DULAWA, S.C. & GEYER, M.A. (1996). Psychopharmacology of prepulse inhibition in mice. Chin. J. Physiol., 39, 139-146.
17. GEYER, M.A. (1999). Assessing prepulse inhibition of startle in wild-type and knockout mice. Psychopharmacology, 147, 11-13.
18. GEYER, M.A. & MARKOU, A. (1995). Animal models of psychiatric disorders. In: Psychopharmacology: The Fourth Generation of Progress, ed. Bloom, F.E. & Kupfer, D.J. pp. 787-798. New York: Raven Press.
19. GEYER, M.A., MCILWAIN, K.L. & PAYLOR, R. (2002). Mouse genetic models for prepulse inhibition: an early review. Mol. Psychiatry, 7, 1039-1053.
20. GEYER, M.A. & SWERDLOW, N.R. (1998). Measurement of startle response, prepulse inhibition, and habituation. In: Current Protocols in Neuroscience, ed. Crawley, J.N. & Skolnick, P. pp. 8.7.1-8. New York: Wiley.
21. GISPEN-DE WIED, C.C. (2000). Stress in schizophrenia: an integrative view. Eur. J. Pharmacol., 405, 375-384.
22. HENRY, S.A., DULAWA, S.C., CONQUET, F. & GEYER, M.A. (1999). Severe disruption of prepulse inhibition in mice lacking mGluR5. Soc. Neurosci. Abstr., 25, 449.
23. JACOBSON, L. (1999). Glucocorticoid replacement, but not corticotropin-releasing hormone deficiency, prevents adrenalectomy-induced anorexia in mice. Endocrinology, 140, 310-317.
24. KELLY, P.M., SEVIOUR, P.W. & IVERSEN, S.D. (1975). Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res., 94, 507-522.
25. KOCH, M. (1999). The neurobiology of startle. Prog. Neurobiol., 59, 107-128.
26. KUMARI, V., SONI, W., MATHEW, V.M. & SHARMA, T. (2000). Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication. Arch. Gen. Psychiatry, 57, 609-614.
27. LARUELLE, M., ABI-DARGHAM, A., Van DYCK, C.H., GIL, R., D'SOUZA, C.D., ERDOS, J., MCCANCE, E., ROSENBLATT, W., FINGADO, C., ZOGHBI, S.S., BALDWIN, R.M., SEIBYL, J.P., KRYSTAL, J.H., CHARNEY, D.S. & INNIS, R. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U.S.A., 93, 9235-9240.
28. LE CUDENNEC, C., NAUDIN, B., DO REGO, J.-C. & COSTENTIN, J. (2002). Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection. Life Sci., 72, 163-171.
29. LINDLEY, S.E., BENGOECHEA, T.G., SCHATZBERG, A.F. & WONG, D.L. (1999). Glucocorticoid effects on mesotelencephalic dopamine neurotransmission. Neuropsychopharmacology, 21, 399-407.
30. MEYER, S.E., CHROUSOS, G.P. & GOLD, P.W. (2001). Major depression and the stress system: a life span perspective. Dev. Psychopathol., 13, 565-580.
31. NUECHTERLEIN, K.H., DAWSON, M.E., VENTURA, J., GITLIN, M., SUBOTNIK, K.L., SNYDER, K.S., MINTZ, J. & BARTZOKIS, G. (1994). The vulnerability/stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatr. Scand., 382, 58-64.
32. OUAGAZZAL, A.-M., JENCK, F. & MOREAU, J.-L. (2001). Druginduced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity? Psychopharmacology, 156, 273-283.
33. PANI, L., PORCELLA, A. & GESSA, G.L. (2000). The role of stress in the pathophysiology of the dopaminergic system. Mol. Psychiatry, 5, 14-21.
34. PIAZZA, P.V., BARROT, M., ROUGE-PONT, F., MARINELLI, M., MACCARI, S., ABROUS, D.N., SIMON, H. & LE MOAL, M. (1996a). Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc. Natl. Acad. Sci. U.S.A., 93, 15445-15450.
35. PIAZZA, P.V. & LE MOAL, M. (1996b). Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol., 36, 359-378.
36. PIAZZA, P.V. & LEMOAL, M. (1997). Glucocorticoids as a biological substrate of reward: physiological pathophysiological implications. Brain Res. Rev., 25, 359-372.
37. 4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J. Neurosci., 19, 4627-4633.
38. REUL, J.M.H.M. & DE KLOET, E.R. (1985). Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology, 117, 2505-2511.
39. REUL, J.M.H.M. & DE KLOET, E.R. (1986). Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. J. Steroid Biochem., 1, 269-272.
40. ROTH, R.H., TAM, S.Y., IDA, Y., YANG, J.X. & DEUTCH, A.Y. (1988). Stress and the mesocorticolimbic dopamine systems. Ann. NY Acad. Sci., 537, 138-147.
41. STEVENS, K.E., BULLOCK, A.E. & COLLINS, A.C. (2001). Chronic corticosterone treatment alters sensory gating in C3H mice. Pharmacol. Biochem. Behav., 69, 359-366.
42. SWERDLOW, N.R., BRAFF, D.L., BAKSHI, V.P. & GEYER, M.A. (1996). An animal model of sensorimotor gating deficits in schizophrenia predicts antipsychotic drug action. In: Antipsychotics, ed. Csernansky, J.G. Berlin: Springer.
43. SWERDLOW, N.R. & GEYER, M.A. (1998). Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bull., 24, 285-301.
44. SWERDLOW, N.R., MANSBACH, R.S., GEYER, M.A., PULVIRENTI, L., KOOB, G.F. & BRAFF, D.L. (1990). Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology, 100, 413-416.
45. TEITELBAUM, H., GIAMMATTEO, P. & MICKLEY, G.A. (1979). Differential effects of localized lesions of n. accumbens on morphine- and amphetamine-induced locomotor hyperactivity in the C57BL/6J mouse. J. Comp. Physiol. Psychol., 93, 745-751.
46. TJURMINA, O.A., ARMANDO, I., SAAVEDRA, J.M., GOLDSTEIN, D.S. & MURPHY, D.L. (2002). Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology, 143, 4520-4526.
47. VAN DEN BUUSE, M., VAN ACKER, S.A.B.E., FLUTTERT, M.J. & DE KLOET, E.R. (2002). Involvement of corticosterone in cardiovascular responses to open-field novelty stress in freely-moving rats. Physiol. Behav., 75, 207-215.
48. VARTY, G.B., WALTERS, N., COHEN-WILLIAMS, M. & CAREY, G.J. (2001). Comparison of apomorphine, amphetamine and dizolcipine disruptions of prepulse inhibition in inbred and outbred mice strains. Eur. J. Pharmacol., 424, 27-36.
49. VRANG, N., KRISTENSEN, P., TANG-CHRISTENSEN, M. & LARSEN, P.J. (2002). Effects of leptin on arcuate pro-opiomelanocortin and cocaine-amphetamine-regulated transcript expression are independent of circulating levels of corticosterone. J. Neuroendocrinol., 14, 880-886.
50. WALKER, E.F. & DIFORIO, D. (1997). Schizophrenia: a neural diathesis-stress model. Psychol. Rev., 104, 667-685.
51. ZOCCHI, A., ORSINI, C., CABIB, S. & PUGLISI-ALLEGRA, S. (1998). Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice. Neuroscience, 82, 521-528.